Providing excellent care and advice is at the heart of everything we do
Your Certificate of Analysis ships with your order not buried on a webpage, right there in the box
We serve patients throughout the Valley with offices in Scottsdale, Phoenix, and Glendale
By drug class, the triple agonists (Pipeline) segment held a 3% share of the market in 2025 and is expected to grow at the fastest CAGR of 29.4% during the projection period
But because GLP-1 meds only work for as long as you take them, there continues to be a growing interest in finding other ways to naturally boost GLP-1 levels
Retatrutide (LY3437943, also referred to informally as "reta peptide") is a synthetic 39-amino-acid peptide developed by Eli Lilly that acts simultaneously on three distinct metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor